We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+21.9%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$57.6B
AUM Growth
+$7.69B
(+15%)
Cap. Flow
+$3.7B
Cap. Flow
% of AUM
6.42%
Top 10 Holdings %
Top 10 Hldgs %
40.22%
Holding
1,054
New
202
Increased
277
Reduced
473
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$3.4B |
| 2 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$885M |
| 3 |
Tesla
TSLA
|
+$252M |
| 4 |
Amazon
AMZN
|
+$156M |
| 5 |
CLVT.PRA
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$379M |
| 2 |
Sherwin-Williams
SHW
|
+$161M |
| 3 |
NVIDIA
NVDA
|
+$154M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$116M |
| 5 |
Boeing
BA
|
+$80M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.6% |
| 2 | Consumer Discretionary | 15.59% |
| 3 | Communication Services | 15.36% |
| 4 | Healthcare | 13.38% |
| 5 | Financials | 10.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Home BancShares
HOMB
$6.15B
| $29M | 0.05% |
1,334,371
-68,869
| -5% | -$1.59M |
|
177
Concentrix
CNXC
$1.55B
| $28.8M | 0.05% |
237,298
-132,782
| -36% | -$18M |
|
178
Alight
ALIT
$402M
| $28.6M | 0.05% |
155,384
+47,402
| +44% | +$8.7M |
|
179
Super Micro Computer
SMCI
$20.9B
| $28.5M | 0.05% |
2,673,640
+1,247,260
| +87% | +$11.3M |
|
180
AAR Corp
AIR
$5.81B
| $28.4M | 0.05% |
+520,020
| New | +$26.9M |
|
181
Paylocity
PCTY
$7.9B
| $27.8M | 0.05% |
140,060
-32,168
| -19% | -$6.33M |
|
182
Insmed
INSM
$29.1B
| $27.8M | 0.05% |
1,628,518
+401,418
| +33% | +$7.8M |
|
|
183
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
| $27.5M | 0.05% |
+736,261
| New | +$885M |
|
|
OPTU
184
Optimum Communications Inc
OPTU
$294M
| $27.5M | 0.05% |
8,044,442
-94,763
| -1% | -$403K |
|
185
Envista
NVST
$4.51B
| $27.5M | 0.05% |
671,684
-2,560
| -0.4% | -$97.3K |
|
|
TWNK
186
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $27.4M | 0.05% |
1,101,592
+9,188
| +0.8% | +$216K |
|
187
Treace Medical Concepts
TMCI
$299M
| $27.3M | 0.05% |
+1,085,187
| New | +$25.5M |
|
188
Xenon Pharmaceuticals
XENE
$6.11B
| $27.2M | 0.05% |
760,567
+83,402
| +12% | +$3.08M |
|
189
UFP Industries
UFPI
$5B
| $27.2M | 0.05% |
342,366
-14,884
| -4% | -$1.27M |
|
|
NVMI
190
Nova
NVMI
$12.3B
| $26.9M | 0.05% |
257,249
+15,111
| +6% | +$1.41M |
|
191
Napco Security Technologies
NSSC
$1.44B
| $26.7M | 0.05% |
710,764
+2,756
| +0.4% | +$87.8K |
|
192
PagerDuty
PD
$917M
| $25.9M | 0.04% |
+740,031
| New | +$21.7M |
|
193
Power Integrations
POWI
$3.44B
| $25.9M | 0.04% |
305,515
+27,270
| +10% | +$2.26M |
|
194
Monolithic Power Systems
MPWR
$68.2B
| $25.6M | 0.04% |
51,055
-860
| -2% | -$395K |
|
195
ICF International
ICFI
$1.66B
| $25.5M | 0.04% |
232,734
+2,094
| +0.9% | +$218K |
|
196
NOV
NOV
$7.33B
| $25.4M | 0.04% |
1,372,171
-5,888
| -0.4% | -$127K |
|
197
Trimble
TRMB
$13.8B
| $25.2M | 0.04% |
481,229
-2,087
| -0.4% | -$111K |
|
|
FNA
198
DELISTED
Paragon 28, Inc.
FNA
| $25.1M | 0.04% |
+1,472,827
| New | +$26.3M |
|
199
Canadian Natural Resources
CNQ
$97.3B
| $24.8M | 0.04% |
+897,866
| New | +$25.4M |
|
|
MODV
200
DELISTED
ModivCare
MODV
| $24.6M | 0.04% |
292,056
+47,203
| +19% | +$4.54M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2023 Portfolio in Review
As of Q1 2023, Loomis, Sayles & Company held 1,054 positions worth $57.6B, up 15% from $49.9B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Loomis, Sayles & Company deployed $3.7B of net new capital in Q1 2023, opening 202 new positions and adding to 277 existing holdings. Its largest new stake was Bank of America Series L: 2,835,020 shares worth $81.1M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Novartis, an estimated $379M trimmed.
- Loomis, Sayles & Company's largest Q1 2023 buy was Bank of America Series L: 2,835,020 shares worth $81.1M.
- Loomis, Sayles & Company added most to Tesla in Q1 2023, an estimated $252M increase.
- Loomis, Sayles & Company's biggest Q1 2023 reduction was Novartis, cutting an estimated $379M.
- Loomis, Sayles & Company fully exited Globus Medical in Q1 2023, selling an estimated $38M.
- Loomis, Sayles & Company's ten largest holdings make up 40% of its $57.6B portfolio in Q1 2023.
- Loomis, Sayles & Company opened 202 new positions and closed 81 in Q1 2023.
- Loomis, Sayles & Company's portfolio value rose 15% quarter-over-quarter to $57.6B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2023, filed 11 May 2023.